litlas
Log inCreate account

Todd A. Fehniger

Active 1997–2026

91
Papers
19,955
Citations
59
h-index
87
i10-index

Citations

Citations per year for Todd A. Fehniger1994: 4 citations1997: 2 citations1998: 7 citations1999: 17 citations2000: 40 citations2001: 66 citations2002: 113 citations2003: 135 citations2004: 185 citations2005: 221 citations2006: 152 citations2007: 145 citations2008: 176 citations2009: 135 citations2010: 159 citations2011: 132 citations2012: 142 citations2013: 129 citations2014: 149 citations2015: 124 citations2016: 152 citations2017: 203 citations2018: 199 citations2019: 738 citations2020: 812 citations2021: 842 citations2022: 776 citations2023: 595 citations2024: 954 citations2025: 486 citations2026: 4 citations1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,438 citing papers, 29.5% of this breakdownChina: 884 citing papers, 10.7% of this breakdownGermany: 541 citing papers, 6.6% of this breakdownItaly: 459 citing papers, 5.6% of this breakdownUnited Kingdom: 399 citing papers, 4.8% of this breakdownFrance: 387 citing papers, 4.7% of this breakdownCanada: 260 citing papers, 3.2% of this breakdownJapan: 225 citing papers, 2.7% of this breakdownAustralia: 218 citing papers, 2.6% of this breakdownSpain: 208 citing papers, 2.5% of this breakdownNetherlands: 195 citing papers, 2.4% of this breakdownSweden: 189 citing papers, 2.3% of this breakdown
0%29.5%Other 22.4%

Institutions

Fields

  • Immunology and Microbiology55.8%
  • Medicine32.4%
  • Biochemistry, Genetics and Molecular Biology9%
  • Neuroscience0.9%
  • Engineering0.5%
  • Agricultural and Biological Sciences0.3%
  • Other1.1%

Topics

  • Immune Cell Function and Interaction20.8%
  • T-cell and B-cell Immunology9.6%
  • CAR-T cell therapy research7.7%
  • Immunotherapy and Immune Responses4.1%
  • IL-33, ST2, and ILC Pathways2.7%
  • Reproductive System and Pregnancy2.6%
  • Other52.5%

Coauthors

All papers

Open in search
  1. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia

    Authors: Rizwan Romee, Maximillian Rosario, Melissa M. Berrien-Elliott, Julia A. Wagner, Brea A. Jewell, Timothy Schappe, Jeffrey Leong, Sara Abdel-Latif, Stephanie Schneider, Sarah Willey, Carly C. Neal, Liyang Yu, Stephen T. Oh, Yi-Shan Lee, Arend Mulder, Frans H.J. Claas, Megan A. Cooper, Todd A. Fehniger - Science Translational Medicine 2016 cited by 924

  2. The biology of human natural killer-cell subsets

    Authors: Megan A. Cooper, Todd A. Fehniger, Michael A. Caligiuri - Trends in Immunology 2001 cited by 2,928

  3. Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance

    Authors: Xuefang Cao, Sheng F. Cai, Todd A. Fehniger, Jiling Song, Lynne Collins, David Piwnica‐Worms, Timothy J. Ley - Immunity 2007 cited by 989

  4. Cytokine activation induces human memory-like NK cells

    Authors: Rizwan Romee, Stephanie Schneider, Jeffrey Leong, Julie Chase, Catherine R. Keppel, Ryan P. Sullivan, Megan A. Cooper, Todd A. Fehniger - Blood 2012 cited by 665

  5. Allogeneic natural killer cell therapy

    Authors: Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger - Blood 2022 cited by 212

  6. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

    Authors: Megan A. Cooper, Todd A. Fehniger, Sarah C. Turner, Kenneth Chen, Bobak A. Ghaheri, Tariq Ghayur, William E. Carson, Michael A. Caligiuri - Blood 2001 cited by 1,426

  7. First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

    Authors: Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott, Peter Westervelt, Michael R. Verneris, John E. Wagner, Daniel J. Weisdorf, Bruce R. Blazar, Celalettin Üstün, Todd E. DeFor, Sithara Vivek, Lindsey Peck, John F. DiPersio, Amanda F. Cashen, Rachel L. Kyllo, Amy Musiek, András Schaffer, Milan J. Anadkat, Ilana S. Rosman, Daniel D. Miller, Jack O. Egan, Emily K. Jeng, Amy D. Rock, Hing C. Wong, Todd A. Fehniger, Jeffrey S. Miller - Blood 2018 cited by 407

  8. CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas

    Authors: Margery Gang, Nancy D. Marín, Pamela Wong, Carly C. Neal, Lynne Marsala, Mark P. Foster, Timothy Schappe, Wei Meng, Jennifer Tran, Maximilian O. Schaettler, Marco L. Davila, Feng Gao, Amanda F. Cashen, Nancy L. Bartlett, Neha Mehta–Shah, Brad S. Kahl, Miriam Kim, Matthew Cooper, John F. DiPersio, Melissa M. Berrien-Elliott, Todd A. Fehniger - Blood 2020 cited by 224

  9. Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

    Authors: Lucila Nassif Kerbauy, Nancy D. Marín, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker‐Hapak, Rafet Başar, Mark P. Foster, Luciana Garcia Melo, Carly C. Neal, Ethan McClain, May Daher, Ana Karen Nunez Cortes, Sweta Desai, Francesca Wei Inng Lim, Mayela Carolina Mendt, Timothy Schappe, Li Li, Hila Shaim, Mayra Shanley, Emily L. Ensley, Nadima Uprety, Pamela Wong, Enli Liu, Sonny Ang, Rong Cai, Vandana Nandivada, Vakul Mohanty, Qi Miao, Yifei Shen, Natalia Baran, Natalie W. Fowlkes, Ken Chen, Luis Muniz-Feliciano, Richard E. Champlin, Yago Nieto, Joachim Koch, Martin Treder, Wolfgang Fischer, Oswaldo Keith Okamoto, Elizabeth J. Shpall, Todd A. Fehniger, Katayoun Rezvani - Clinical Cancer Research 2021 cited by 151

  10. Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

    Authors: Melissa M. Berrien-Elliott, Michelle Becker‐Hapak, Amanda F. Cashen, Miriam T. Jacobs, Pamela Wong, Mark P. Foster, Ethan McClain, Sweta Desai, Patrick Pence, Sarah Cooley, Claudio G. Brunstein, Feng Gao, Camille N. Abboud, Geoffrey L. Uy, Peter Westervelt, Meagan A. Jacoby, Iskra Pusic, Keith Stockerl‐Goldstein, Mark A. Schroeder, John F. DiPersio, Patrick Soon‐Shiong, Jeffrey S. Miller, Todd A. Fehniger - Blood 2021 cited by 104

  11. Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant

    Authors: Jeffrey J. Bednarski, Clare Zimmerman, Melissa M. Berrien-Elliott, Jennifer A. Foltz, Michelle Becker‐Hapak, Carly C. Neal, Mark P. Foster, Timothy Schappe, Ethan McClain, Patrick Pence, Sweta Desai, Samantha Kersting-Schadek, Pamela Wong, David A. Russler‐Germain, Bryan Fisk, Wen‐Rong Lie, Jeremy Eisele, Stephanie Hyde, Sima Bhatt, Obi L. Griffith, Malachi Griffith, Allegra A. Petti, Amanda F. Cashen, Todd A. Fehniger - Blood 2021 cited by 163

  12. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Authors: John S. Welch, Allegra A. Petti, Christopher A. Miller, Catrina C. Fronick, Michelle D. O’Laughlin, Robert S. Fulton, Richard K. Wilson, Jack Baty, Eric J. Duncavage, Bevan Tandon, Yi-Shan Lee, Lukas D. Wartman, Geoffrey L. Uy, Armin Ghobadi, Michael H. Tomasson, Iskra Pusic, Rizwan Romee, Todd A. Fehniger, Keith Stockerl‐Goldstein, Ravi Vij, Stephen T. Oh, Camille N. Abboud, Amanda F. Cashen, Mark A. Schroeder, Meagan A. Jacoby, Sharon E. Heath, Kierstin Luber, Megan Janke, Andrew Hantel, Niloufer Khan, Madina Sukhanova, Randall W. Knoebel, Wendy Stock, Timothy A. Graubert, Matthew J. Walter, Peter Westervelt, Daniel C. Link, John F. DiPersio, Timothy J. Ley - New England Journal of Medicine 2016 cited by 784

  13. CD56bright NK cells exhibit potent antitumor responses following IL-15 priming

    Authors: Julia Wagner, Maximillian Rosario, Rizwan Romee, Melissa M. Berrien-Elliott, Stephanie E. Schneider, Jeffrey Leong, Ryan Sullivan, Brea A. Jewell, Michelle Becker‐Hapak, Timothy Schappe, Sara Abdel-Latif, Aaron R. Ireland, Devika Jaishankar, Justin King, Ravi Vij, Dennis Clement, Jodie P. Goodridge, Karl‐Johan Malmberg, Hing C. Wong, Todd A. Fehniger - Journal of Clinical Investigation 2017 cited by 311

  14. Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia

    Authors: Melissa M. Berrien-Elliott, Jennifer A. Foltz, David A. Russler‐Germain, Carly C. Neal, Jennifer Tran, Margery Gang, Pamela Wong, Bryan Fisk, Celia C. Cubitt, Nancy D. Marín, Alice Y. Zhou, Miriam T. Jacobs, Mark P. Foster, Timothy Schappe, Ethan McClain, Samantha Kersting-Schadek, Sweta Desai, Patrick Pence, Michelle Becker‐Hapak, Jeremy Eisele, Matthew Mosior, Lynne Marsala, Obi L. Griffith, Malachi Griffith, Saad M. Khan, David H. Spencer, John F. DiPersio, Rizwan Romee, Geoffrey L. Uy, Camille N. Abboud, Armin Ghobadi, Peter Westervelt, Keith Stockerl‐Goldstein, Mark A. Schroeder, Fei Wan, Wen‐Rong Lie, Patrick Soon‐Shiong, Allegra A. Petti, Amanda F. Cashen, Todd A. Fehniger - Science Translational Medicine 2022 cited by 119

  15. Interleukin 15: biology and relevance to human disease

    Authors: Todd A. Fehniger, Michael A. Caligiuri - Blood 2001 cited by 959

  16. Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia

    Authors: Melissa M. Berrien-Elliott, Amanda F. Cashen, Celia C. Cubitt, Carly C. Neal, Pamela Wong, Julia A. Wagner, Mark P. Foster, Timothy Schappe, Sweta Desai, Ethan McClain, Michelle Becker‐Hapak, Jennifer A. Foltz, Matthew Cooper, Natália Jaeger, Sridhar Nonavinkere Srivatsan, Feng Gao, Rizwan Romee, Camille N. Abboud, Geoffrey L. Uy, Peter Westervelt, Meagan A. Jacoby, Iskra Pusic, Keith Stockerl‐Goldstein, Mark A. Schroeder, John F. DiPersio, Todd A. Fehniger - Cancer Discovery 2020 cited by 146

  17. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

    Authors: Todd A. Fehniger, Megan A. Cooper, Gerard J. Nuovo, Marina Cella, Fabio Facchetti, Marco Colonna, Michael A. Caligiuri - Blood 2003 cited by 842

  18. Memory-like natural killer cells for cancer immunotherapy

    Authors: Margery Gang, Pamela Wong, Melissa M. Berrien-Elliott, Todd A. Fehniger - Seminars in Hematology 2020 cited by 96

  19. Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction

    Authors: Mehmet Emrah Selli, Jack H. Landmann, Marina Terekhova, John Lattin, Amanda Heard, Yu-Sung Hsu, Tien-Ching Chang, Jufang Chang, John M. Warrington, Helen Ha, Natalie L. Kingston, Graham D. Hogg, Michael Slade, Melissa M. Berrien-Elliott, Mark P. Foster, Samantha Kersting-Schadek, Agata Gruszczyńska, David G. DeNardo, Todd A. Fehniger, Maxim N. Artyomov, Nathan Singh - Blood 2023 cited by 50

  20. Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells

    Authors: Jeffrey Leong, Julie Chase, Rizwan Romee, Stephanie Schneider, Ryan P. Sullivan, Megan A. Cooper, Todd A. Fehniger - Biology of Blood and Marrow Transplantation 2014 cited by 281

  21. Guidelines for the use of flow cytometry and cell sorting in immunological studies *

    Authors: Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, Mübeccel Akdiş, Immanuel Andrä, Francesco Annunziato, Petra Bächer, Vincenzo Barnaba, Luca Battistini, Wolfgang Bauer, Sabine Baumgart, Burkhard Becher, Wolfgang Beisker, Claudia Berek, Alfonso Blanco, Giovanna Borsellino, Philip E. Boulais, Ryan R. Brinkman, Martin Büscher, Dirk H. Busch, Timothy Bushnell, Xuetao Cao, Andrea Cavani, Pratip K. Chattopadhyay, Qingyu Cheng, Sue Chow, Mario Clerici, Anne Cooke, Antonio Cosma, Lorenzo Cosmi, Ana Cumano, Van Duc Dang, Derek Davies, Sara De Biasi, Genny Del Zotto, Silvia Della Bella, Paolo Dellabona, Günnur Deniz, Mark C. Dessing, Andreas Diefenbach, James P. Di Santo, Francesco Dieli, Andreas Dolf, Vera S. Donnenberg, Thomas Dörner, Götz R. A. Ehrhardt, Elmar Endl, Pablo Engel, Britta Engelhardt, Charlotte Esser, Bart Everts, Anita Dreher, Christine S. Falk, Todd A. Fehniger, Andrew Filby, Simon Fillatreau, Marie Follo, Irmgard Förster, John R. Foster, Gemma A. Foulds, Paul S. Frenette, David W. Galbraith, Natalio Garbi, Maria Dolores García‐Godoy, Jens Geginat, Kamran Ghoreschi, Lara Gibellini, Christoph Goettlinger, Carl S. Goodyear, Andrea Gori, Jane L. Grogan, Mor Gross, Andreas Grützkau, Daryl Grummitt, Jonas Hahn, Quirin Hammer, Anja E. Hauser, David L. Haviland, David W. Hedley, Guadalupe Herrera, Martin Herrmann, Falk Hiepe, Tristan Holland, Pleun Hombrink, Jessica P. Houston, Bimba F. Hoyer, Bo Huang, Christopher A. Hunter, Anna Iannone, Hans‐Martin Jäck, Beatriz Jávega, Stipan Jonjić, Kerstin Juelke, Steffen Jung, Toralf Kaiser, Tomáš Kalina, Baerbel Keller, Srijit Khan, Deborah Kienhöfer, Thomas Kroneis and 136 more - European Journal of Immunology 2017 cited by 552

  22. A potential role for interleukin-15 in the regulation of human natural killer cell survival.

    Authors: William E. Carson, Todd A. Fehniger, Subrata Haldar, K Eckhert, M J Lindemann, C F Lai, Carlo M. Croce, Heinz Baumann, Michael A. Caligiuri - Journal of Clinical Investigation 1997 cited by 419

  23. Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development

    Authors: Carissa Dege, Katherine H. Fegan, J. Philip Creamer, Melissa M. Berrien-Elliott, Stephanie A. Luff, Darren Kim, Julia A. Wagner, Paul D. Kingsley, Kathleen E. McGrath, Todd A. Fehniger, James Palis, Christopher M. Sturgeon - Developmental Cell 2020 cited by 91

  24. Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis

    Authors: Madison R. Mack, Jonathan R. Brestoff, Melissa M. Berrien-Elliott, Anna M. Trier, Ting-Lin B. Yang, Matthew McCullen, Patrick L. Collins, Haixia Niu, Nancy D. Bodet, Julia A. Wagner, Eugene Park, Amy Xu, Fang Wang, Rebecca Chibnall, Carrie Heffington, Friederike Kreisel, David J. Margolis, David Sheinbein, Paola Lovato, Éric Vivier, Marina Cella, Marco Colonna, Wayne M. Yokoyama, Eugene M. Oltz, Todd A. Fehniger, Brian Kim - Science Translational Medicine 2020 cited by 108